Catalyst Wire Dossier Catalyst Wire Dossier
CLINICAL_TRIALS trial_result · 2017-12-19

Clinical Trial Update: AG200-15 Transdermal Contraceptive Delivery System (TCDS) of Levonorgestrel and Ethinyl Estradiol [Phase 1]

View source ↗

Summary

Phase 1 trial update for AG200-15 transdermal contraceptive delivery system delivering levonorgestrel and ethinyl estradiol; study completed with results posted…

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

Drugs mentioned

  • AG200-15 Transdermal Contraceptive Delivery System (levonorgestrel and ethinyl estradiol)

Snippet

Sponsor: Agile Therapeutics | Conditions: Healthy | Phase 1 | Status: COMPLETED | Results posted: 2017-12-19